Literature DB >> 23435968

Research ethics committee auditing: the experience of a university hospital.

Daniela Marchetti1, Angelico Spagnolo, Marina Cicerone, Fidelia Cascini, Giuseppe La Monaca, Antonio G Spagnolo.   

Abstract

The authors report the first Italian experience of a research ethics committee (REC) audit focused on the evaluation of the REC's compliance with standard operating procedures, requirements in insurance coverage, informed consent, protection of privacy and confidentiality, predictable risks/harms, selection of subjects, withdrawal criteria and other issues, such as advertisement details and justification of placebo. The internal audit was conducted over a two-year period (March 2009-February 2011) divided into quarters to better value the influence of the new insurance coverage regulation that came into effect in March 2010 (Ministerial Decree of 14 July, 2009) and expand the requirements to safeguard participants in clinical drug trials including other critical items as information and consent and the risks to benefits ratio. Out of a total of 639 REC's opinions and research studies, 316 were reviewed. Regarding the insurance policy requirements, Auditor/REC non-compliance occurred only in one case. The highest number of Auditor/REC non-compliance was in regard to information and consent, which should have incurred a suspended decision rather than a favorable opinion. This internal audit shows the importance and the difficulty of the review process. For this reason, specific courses for members of the research ethics committee and for those who aspire to become auditors will be provided. There may also be efforts to improve the standard operating procedures already in place.

Entities:  

Mesh:

Year:  2013        PMID: 23435968     DOI: 10.1007/s10730-013-9210-8

Source DB:  PubMed          Journal:  HEC Forum        ISSN: 0956-2737


  6 in total

1.  European Clinical Trials Directive: the Italian position.

Authors:  Umberto Filibeck; Antonio Addis; Carlo Tomino; Nello Martini
Journal:  Lancet       Date:  2004-05-15       Impact factor: 79.321

2.  Insurance and clinical trials.

Authors:  Roberta Minacori; Dario Sacchini; Marina Cicerone; Antonio G Spagnolo
Journal:  Contemp Clin Trials       Date:  2012-03-03       Impact factor: 2.226

3.  Research ethics committee audit: differences between committees.

Authors:  M E Redshaw; A Harris; J D Baum
Journal:  J Med Ethics       Date:  1996-04       Impact factor: 2.903

4.  Gatekeeping and the FDA's Role in Human Subjects Protection.

Authors:  Daniel Carpenter
Journal:  Virtual Mentor       Date:  2004-11-01

5.  Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine (adopted by the Committee of Ministers on 19 November 1996). Council of Europe Convention of Biomedicine.

Authors: 
Journal:  Hum Reprod       Date:  1997-09       Impact factor: 6.918

6.  How do we know that research ethics committees are really working? The neglected role of outcomes assessment in research ethics review.

Authors:  Carl H Coleman; Marie-Charlotte Bouësseau
Journal:  BMC Med Ethics       Date:  2008-03-28       Impact factor: 2.652

  6 in total
  1 in total

1.  Role of microRNA-4458 in patients with non-small-cell lung cancer.

Authors:  Lidao Bao; Linlin Wang; Guomin Wei; Yuehong Wang; Gerile Wuyun; Agula Bo
Journal:  Oncol Lett       Date:  2016-09-22       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.